HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

[Unusual course in 2 patients with testicular teratoma during vinblastine-cyclophosphamide chemotherapy].

Abstract
Two patients with metastatic embryonal testicular cancer achieved complete remission receiving a vinblastine-cyclophosphamide combination chemotherapy. After a previous treatment with vinblastine-bleomycin one patient had developed progressive disease, the other one had attained partial remission only. Because of our own experiences and because of the results in single agent chemotherapy this well tolerated vinblastine-cyclophosphamide combination is proposed as maintenance therapy for testicular teratoma. Other maintenance therapies according to the literature and the problem of maintenance therapy in general are discussed.
AuthorsM Freund, P Ostendorf, K Wilms
JournalOnkologie (Onkologie) Vol. 4 Issue 3 Pg. 150-4 (Jun 1981) ISSN: 0378-584X [Print] Switzerland
Vernacular TitleUngewöhnlicher Verlauf bei zwei Patienten mit Hoden-Teratom unter Vinblastin-Cyclophosphamid-Chemotherapie.
PMID6167922 (Publication Type: Case Reports, English Abstract, Journal Article)
Chemical References
  • Bleomycin
  • Vinblastine
  • Cyclophosphamide
Topics
  • Adult
  • Bleomycin (therapeutic use)
  • Cyclophosphamide (therapeutic use)
  • Drug Therapy, Combination
  • Humans
  • Lymphatic Metastasis
  • Male
  • Radiotherapy Dosage
  • Teratoma (drug therapy, secondary)
  • Testicular Neoplasms (drug therapy, secondary)
  • Vinblastine (therapeutic use)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: